Cargando…
Modification of gastric cancer risk associated with proton pump inhibitors by aspirin after Helicobacter pylori eradication
AIM: Although proton pump inhibitors (PPIs) can prevent aspirin-induced upper gastrointestinal bleeding, a clinical dilemma exists as long-term use of PPI may also increase the risk of gastric cancer even after Helicobacter pylori (HP) eradication. We aimed to investigate the potential interaction b...
Autores principales: | Cheung, Ka Shing, Leung, Wai K. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Impact Journals LLC
2018
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6319331/ https://www.ncbi.nlm.nih.gov/pubmed/30651922 http://dx.doi.org/10.18632/oncotarget.26382 |
Ejemplares similares
-
Risk of gastric cancer development after eradication of Helicobacter pylori
por: Cheung, Ka-Shing, et al.
Publicado: (2018) -
Divergent trends of hospitalizations for upper and lower gastrointestinal bleeding based on population prescriptions of aspirin, proton pump inhibitors and Helicobacter pylori eradication therapy: Trends of upper and lower gastrointestinal bleeding
por: Guo, Chuan‐Guo, et al.
Publicado: (2021) -
Comparative study: Vonoprazan and proton pump inhibitors in Helicobacter pylori eradication therapy
por: Sakurai, Kouichi, et al.
Publicado: (2017) -
Inflammatory microRNAs in gastric mucosa are modulated by Helicobacter pylori infection and proton-pump inhibitors but not by aspirin or NSAIDs
por: Vasapolli, Riccardo, et al.
Publicado: (2021) -
Addition of cranberry to proton pump inhibitor-based triple therapy for Helicobacter pylori eradication
por: Seyyedmajidi, Mohammadreza, et al.
Publicado: (2016)